Literature DB >> 3368008

Investigations of cardiovascular 5-hydroxytryptamine receptor subtypes in the rat.

J R Docherty1.   

Abstract

Peripheral 5-HT receptor-mediated responses were examined in pithed spontaneously hypertensive rats and normotensive wistar rats. Responses examined were: Pressor and depressor responses, tachycardia and inhibition of stimulation-evoked tachycardia. In pithed spontaneously hypertensive rats, 5-HT, but not the 5-HT1-selective agonist 5-carboxamidotryptamine, produced pressor responses, and these were potently antagonised by the 5-HT2-selective antagonists ketanserin and LY 53857. In pithed spontaneously hypertensive rats, the tachycardia to 5-HT was abolished by a combination of the 5-HT2 receptor antagonist LY 53857 and propranolol, suggesting that the tachycardia is mediated by 5-HT2 receptors and by release of noradrenaline. In pithed spontaneously hypertensive rats, 5-carboxamidotryptamine, 5-HT, and to a lesser extent the 5-HT1 receptor agonist RU 24969, but not the 5-HT1A receptor agonist 8-OH-DPAT, produced depressor responses which were antagonised by methysergide and metitepin, but which do not clearly fit with any of the 5-HT1 ligand binding sites. In pithed normotensive wistar rat, 5-carboxamidotryptamine was approximately 100 times more potent than 5-HT and 8-OH-DPAT at inhibiting the cardio-acceleration produced by single pulse electrical stimulation and this inhibition was antagonised by metitepin, so that the response is mediated by 5-HT1 receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3368008     DOI: 10.1007/bf00169468

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  34 in total

1.  Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors.

Authors:  P R Saxena; E J Mylecharane; J Heiligers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

2.  An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney. Apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1C subtypes.

Authors:  K G Charlton; R A Bond; D E Clarke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

3.  A comparison of pre- and post-junctional potencies of several alpha-adrenoceptor agonists in the cardiovascular system and anococcygeus muscle of the rat. Evidence for two types of post-junctional alpha-adrenoceptor.

Authors:  J R Docherty; J C McGrath
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

4.  Divergent effects of cyproheptadine and R 50 656, a 5-HT2 antagonist, on the cardiovascular response to 5-hydroxytryptamine in rats.

Authors:  M K Krstić; Z S Katusić
Journal:  Eur J Pharmacol       Date:  1982-11-19       Impact factor: 4.432

5.  Effects of mianserin, desipramine and maprotiline on blood pressure responses evoked by acetylcholine, histamine and 5-hydroxytryptamine in rats.

Authors:  I Cavero; F Lefèvre-Borg; A G Roach
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

6.  An investigation of presynaptic alpha-adrenoceptor subtypes in the pithed rat heart and in the rat isolated vas deferens.

Authors:  J R Docherty
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

7.  A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists.

Authors:  W Feniuk; P P Humphrey; M J Perren; A D Watts
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

8.  Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat.

Authors:  M Göthert; E Schlicker; P Kollecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

9.  3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic.

Authors:  W U Dompert; T Glaser; J Traber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

10.  MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.

Authors:  J R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

View more
  12 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle.

Authors:  U Jahnel; J Rupp; R Ertl; H Nawrath
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

3.  Inhibitory effect of 5-hydroxytryptamine on penile erectile function in the rat.

Authors:  J P Finberg; Y Vardi
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

4.  The atypical 5-HT2 receptor mediating tachycardia in pithed rats: pharmacological correlation with the 5-HT2A receptor subtype.

Authors:  David Centurión; Mario I Ortiz; Pramod R Saxena; Carlos M Villalón
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

5.  Cardiovascular stability with rapid intravenous infusion of ondansetron.

Authors:  J S Heyman; M L Young; R J Bagshaw; W J Levy; R T Geer; S J Aukburg; A F Joslyn; T J Conahan
Journal:  Can J Anaesth       Date:  1993-05       Impact factor: 5.063

6.  Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.

Authors:  J McDaid; J R Docherty
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

7.  A 5-hydroxytryptamine receptor in human atrium.

Authors:  A J Kaumann; L Sanders; A M Brown; K J Murray; M J Brown
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

8.  Diverse inotropic effects of 5-hydroxytryptamine in heart muscles of various mammalian species.

Authors:  H Zaizen; S Imanishi; M Nasu; M Arita
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

9.  Suppression of reperfusion-induced arrhythmias with combined administration of 5-HT2 and thromboxane A2 antagonists.

Authors:  L A Shaw; S J Coker
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 10.  Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.

Authors:  Carlos M Villalón; David Centurión
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-08-17       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.